Urban mobility is one of the most significant factors in the successful development and sustainable future of large cities. The increasing demand for fast, safe, and eco-friendly transportation services is a trend in modern society. These requirements pose the challenge of finding corresponding solutions for efficient mobility of people in urban areas. However, many problems are caused by the increased traffic in cities, leading to high congestion, negative impacts on the environment, rising security challenges, etc. Therefore, the research community and other stakeholders have increased their focus on finding solutions for these issues. The Internet of Things (IoT) has enabled the development of efficient and cost-effective solutions to enhance urban mobility. Enabling IoT technologies has become a significant driver for smart mobility concept development. The continuous development of IoT has led to various applications focused on urban mobility improvement. This paper presents some IoT possibilities and potentials for developing solutions for smart urban mobility.
The development of information society and broadband Internet is key indicators of social and economic change. They transform the way companies, political systems, and citizens communicate with each other. Today, we talk about various regional and national initiatives to first stabilize and then improve the economies of countries through the development of the Internet and information society. The European Union has recognized information technology as a major factor influencing economic growth and innovation. Among the seven flagship initiatives of the Europe 2020 economic strategy is the Digital Agenda for Europe. This shows the importance that information technologies have in the development of the modern economy. In this paper, we analyze the current state of development of the information society and broadband Internet access in Bosnia and Herzegovina. We highlight the necessity of considering mechanisms for the development of broadband access. We analyzed the current situation and progress in the implementation of the Digital Agenda guidelines in EU countries. The aim of this research is to highlight the advantages of using EU strategic guidelines to improve and develop the current situation in the field of broadband Internet in Bosnia and Herzegovina
Ginkgo (Ginkgo biloba L.) is one of the most distinctive plants, characterized by excellent resistance to various environmental conditions. It is used as an ornamental plant and is recognized as a medicinal plant in both traditional and Western medicine. Its bioactive potential is associated with the presence of flavonoids and terpene trilactones, but many other compounds may also have synergistic effects. Flavonoid dimers—biflavonoids—are important constituents of ginkgophytopharmaceuticals. Currently, the presence of 13 biflavonoids has been reported in ginkgo, of which amentoflavone, bilobetin, sciadopitysin, ginkgetin and isoginkgetin are the most common. Their role in plants remains unknown, but their bioactivity and potential role in the management of human health are better investigated. In this review, we have provided an overview of the chemistry, diversity and biological factors that influence the presence of biflavonoids in ginkgo, as well as their bioactive and health-related properties. We have focused on their antioxidant, anticancer, antiviral, antibacterial, antifungal and anti-inflammatory activities as well as their potential role in the treatment of cardiovascular, metabolic and neurodegenerative diseases. We also highlighted their potential toxicity and pointed out further research directions.
Deregulation of TGF‐β family signalling underlies some serious human diseases, including cancer, the Marfan syndromes, and other connective tissue disorders. Recent work in my lab has focused on working out how mutations in key components of TGF‐β family signalling pathways cause these diseases.
Endometriosis is a common gynecological hurting disorder in which tissue is similar to the tissue that normally lines the inner layer of the uterus. It often causes fertility problems. Unfortunately, effective treatments are limited. Therefore it's important to explore an imperative and easily accessible treatment to alleviate the probable pathologies and preserve fertility in endometriosis. Consequently, we aimed to investigate the effects of metformin, letrozole, and atorvastatin on inflammation and apoptosis in experimentally induced ovarian and peritoneal endometriosis in rat models. In the present study, 35 rats were randomly divided into five groups. Group 1: sham-operated control group. Group 2: untreated endometriosis group. Group 3: given 100 mg/kg/day of oral metformin. Group 4: given 0.1 mg/kg/day of oral letrozole. Group 5: given 2.5 mg/kg/day of oral atorvastatin. At the end of the 28 days, we examined Ki67, Bax and Bcl-2 immunoexpressions in ovarian and peritoneal tissues, and IL-6, IL-8, and TNF-α levels were evaluated from the peritoneal fluid. All medical treatment groups showed a significant decrease in Ki67 expression. A significant increase in Bax expression was also observed in all samples from all medical treatment groups (other than the untreated endometriosis groups). Further, a significant decrease in Bcl-2 expression was found in all medical treatment groups. IL-6, IL-8, and TNF-α levels were significantly lower in all medical treatment groups than in the endometriosis groups. In conclusion; Metformin, letrozole, and atorvastatin showed apoptosis induction and anti-inflammatory effects on both ovarian and peritoneal endometriosis in experimental models.
All processes in the production and distribution of material goods, which include material and interactive information flows, are united by the term “Logistics” and are realized within the logistics processes. Logistics processes hide large technological and economic reserves that need to be identified, located and used. At the EU level, a new philosophy of realization of quality logistics processes has been created in the past decades, and it is increasingly including the environmental aspect by introducing the term Green Logistics, which highlights the demand for a healthy environment. The level of logistics process technology is still far below the level of development of material production technology, which is the main reason for giving strategic importance to the rationalization and optimization of logistics processes at the global level in order at reducing the costs of all participants in the implementation of the process, and especially in the direction of raising the quality of services and meeting the increasingly stringent requirements of service users.
Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) share common culprit foods and potential pathophysiological factors. However, how diet may contribute to disease course and whether this differs between both entities is unclear. We therefore investigated the association of dietary indices with intestinal inflammation and gastrointestinal symptoms in both IBD and IBS patients. Food frequency questionnaires from 238 IBD, 261 IBS and 195 healthy controls (HC) were available to calculate the overall diet quality by the Dutch Healthy Diet-Index 2015 (DHD-2015) and its inflammatory potential by the Adapted Dietary Inflammatory Index (ADII). Intestinal inflammation and symptoms were evaluated by faecal calprotectin and the Gastrointestinal Symptom Rating Scale, respectively. The DHD-2015 was lower in IBD and IBS versus HC (p < 0.001), being associated with calprotectin levels in IBD (b = −4.009, p = 0.006), and with abdominal pain (b = −0.012, p = 0.023) and reflux syndrome (b = −0.016, p = 0.004) in IBS. ADII scores were comparable between groups and were only associated with abdominal pain in IBD (b = 0.194, p = 0.004). In this side-by-side comparison, we found a lower diet quality that was differentially associated with disease characteristics in IBD versus IBS patients. Longitudinal studies are needed to further investigate the role of dietary factors in the development of flares and predominant symptoms.
Nema pronađenih rezultata, molimo da izmjenite uslove pretrage i pokušate ponovo!
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više